Research Articles

Why Do We Need New Drug Classes for HIV Treatment and Prevention?

Waheed AA, Tachedjian G

Barriers, Facilitators and Priorities for Implementation of WHO Maternal and Perinatal Health Guidelines in Four Lower-Income Countries: A GREAT Network Research Activity.

Vogel JP, Moore JE, Timmings C, Khan S, Khan DN, Defar A, Hadush A, Minwyelet Terefe M, Teshome L, Ba-Thike K, Than KK, Makuwani A, Mbaruku G, Mrisho M, Mugerwa KY, Puchalski Ritchie LM, Rashid S, Straus SE, Gülmezoglu AM

International estimated fetal weight standards of the INTERGROWTH-21st Project.

Stirnemann J, Villar J, Salomon LJ, Ohuma E, Ruyan P, Altman DG, Nosten F, Craik R, Munim S, Cheikh Ismail L, Barros FC, Lambert A, Norris S, Carvalho M, Jaffer YA, Noble JA, Bertino E, Gravett MG, Purwar M, Victora CG, Uauy R, Bhutta Z, Kennedy S, Papageorghiou AT

Maternal, Newborn + Child Health

Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study.

Martinello M, Gane E, Hellard M, Sasadeusz J, Shaw D, Petoumenos K, Applegate T, Grebely J, Maire L, Marks P, Dore GJ, Matthews GV

Genital inflammation, immune activation and risk of sexual HIV acquisition.

Passmore JA, Jaspan HB, Masson L

Why do general practitioners prescribe antibiotics for upper respiratory tract infections to meet patient expectations: a mixed methods study.

Fletcher-Lartey S, Yee M, Gaarslev C, Khan R